Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             151 results found
no title author magazine year volume issue page(s) type
1 A controlled trial of antidepressants in patients with Parkinson’s disease and depression Morgan, John C.
2009
4 p. 263-265
article
2 Adenosine A2A Antagonists in Parkinson’s Disease: What’s Next? Hickey, Patrick
2012
4 p. 376-385
article
3 Agrypnia Excitata Provini, Federica
2013
4 p. 1-6
article
4 Allergic Rhinitis and Chronic Daily Headaches: Is There a Link? Gryglas, Anna
2016
4 p. 1-8
article
5 Alternative approaches to epilepsy treatment McElroy-Cox, Caitlin
2009
4 p. 313-318
article
6 Alternative Surgical Approaches in Epilepsy Gigante, Paul R.
2011
4 p. 404-408
article
7 Anterocollis and Camptocormia in Parkinsonism: A Current Assessment Revuelta, Gonzalo J.
2012
4 p. 386-391
article
8 Antiepileptic Drugs and Neurodevelopment: An Update Palac, Susan
2011
4 p. 423-427
article
9 An update on brain stimulation for epilepsy Anderson, Christopher Todd
2009
4 p. 327-332
article
10 An update on essential tremor Elble, Rodger J.
2009
4 p. 273-277
article
11 An Update on Gene Therapy in Parkinson’s Disease Witt, Jennifer
2011
4 p. 362-370
article
12 An update on inherited ataxias Schmitz-Hübsch, Tanja
2008
4 p. 310-319
article
13 An Update on Psychogenic Movement Disorders Ellenstein, Aviva
2011
4 p. 396-403
article
14 An update on the pathophysiology and genetics of restless legs syndrome Trotti, Lynn Marie
2008
4 p. 281-287
article
15 An Update on Tourette Syndrome Kimber, Thomas E.
2010
4 p. 286-291
article
16 A Review and Update on Tourette Syndrome: Where Is the Field Headed? Gunduz, Aysegul
2016
4 p. 1-13
article
17 A single-blind trial of bilateral globus pallidus internus deep brain stimulation in medically refractory cervical dystonia Morgan, John C.
2008
4 p. 279-280
article
18 Behavioral Treatments for Migraine Management: Useful at Each Step of Migraine Care Singer, Alexandra B.
2015
4 p. 1-8
article
19 Bilateral deep brain stimulation versus best medical therapy for patients with advanced Parkinson’s disease Mehta, Shyamal H.
2009
4 p. 266-267
article
20 Bioequivalence of antiepileptic drugs: How close is close enough? Gidal, Barry E.
2009
4 p. 333-337
article
21 Biofeedback and Epilepsy Nagai, Yoko
2011
4 p. 443-450
article
22 Botulinum Toxin for the Treatment of Movement Disorders Thenganatt, Mary Ann
2012
4 p. 399-409
article
23 Cell-based therapies in Parkinson’s disease Greene, Paul
2009
4 p. 292-297
article
24 Cerebral Lactate Metabolism After Traumatic Brain Injury Patet, Camille
2016
4 p. 1-7
article
25 Challenges and Controversies in the Genetic Diagnosis of Hereditary Spastic Paraplegia Saputra, Lydia

4 article
26 Chronopharmacology of Anti-Convulsive Therapy Ramgopal, Sriram
2013
4 p. 1-15
article
27 Circadian Disruption Associated with Alzheimer’s Disease Saeed, Yumna
2017
4 p. 1-8
article
28 CNS Demyelination with TNF-α Blockers Kemanetzoglou, Elissavet
2017
4 p. 1-15
article
29 Coccidioidal Meningitis: A Review on Diagnosis, Treatment, and Management of Complications Johnson, Royce
2018
4 p. 1-8
article
30 Concussion and Football: a Review and Editorial Abdullah, Kalil G.
2015
4 p. 1-4
article
31 Continuous EEG Monitoring in the Intensive Care Unit Kennedy, Jeffrey D.
2012
4 p. 419-428
article
32 Continuous Electroencephalography Monitoring in Neonates Shellhaas, Renée A.
2012
4 p. 429-435
article
33 Critical Care of the Potential Organ Donor Dare, Anna J.
2012
4 p. 456-465
article
34 Critical Care of the Potential Organ Donor Dare, Anna J.

4 p. 456-465
article
35 Daytime Sleepiness and Myotonic Dystrophy Laberge, Luc
2013
4 p. 1-8
article
36 Depression and epilepsy: Do glucocorticoids and glutamate explain their relationship? Kanner, Andres M.
2009
4 p. 307-312
article
37 Diagnostic Error in Neuro-ophthalmology: Avenues to Improve Muro-Fuentes, Elena A.

4 p. 243-256
article
38 Dietary Interventions to Lower the Risk of Stroke Boden-Albala, Bernadette
2015
4 p. 1-8
article
39 Differential Diagnosis of Chorea Walker, Ruth H.
2011
4 p. 385-395
article
40 Digital Technology in Movement Disorders: Updates, Applications, and Challenges Adams, Jamie L.

4 article
41 EEG Monitoring of the Epileptic Newborn Pisani, Francesco

4 article
42 Emergency Department and Inpatient Management of Headache in Adults Robblee, Jennifer

4 article
43 Epilepsy and Autism: Neurodevelopmental Perspective Tuchman, Roberto
2011
4 p. 428-434
article
44 Epilepsy and stigma: An update and critical review Jacoby, Ann
2008
4 p. 339-344
article
45 Epilepsy in the developing world Carpio, Arturo
2009
4 p. 319-326
article
46 Epilepsy Surgery: Still Underutilized After All These Years Bazil, Carl W.
2012
4 p. 348-349
article
47 Epileptogenesis in Common Parasitic Infections Mazumder, Rajarshi

4 p. 285-291
article
48 Fatal Familial Insomnia: Clinical Aspects and Molecular Alterations Llorens, Franc
2017
4 p. 1-7
article
49 Fulminant Idiopathic Intracranial Hypertension Bouffard, Marc A.

4 article
50 Gastrointestinal Features of Parkinson’s Disease Cloud, Leslie J.
2011
4 p. 379-384
article
51 Genetics of Epilepsy and Relevance to Current Practice Michelucci, Roberto
2012
4 p. 445-455
article
52 Hashimoto’s Encephalopathy: Case Series and Literature Review Chaudhuri, Jasodhara

4 p. 167-175
article
53 Hormonal Therapy for Epilepsy Stevens, Scott J.
2011
4 p. 435-442
article
54 Huntington’s Disease—Update on Treatments Wyant, Kara J.
2017
4 p. 1-11
article
55 Immunotherapy Approaches for Malignant Glioma From 2007 to 2009 Johnson, Laura A.
2010
4 p. 259-266
article
56 Inpatient Management of Migraine Marmura, Michael J.
2015
4 p. 1-10
article
57 Insights into the Mechanisms That May Clarify Obesity as a Risk Factor for Multiple Sclerosis Huitema, Marije J. D.
2018
4 p. 1-9
article
58 Integrated Approach for Pain Management in Parkinson Disease Geroin, Christian
2016
4 p. 1-11
article
59 Intractable Generalized Epilepsy: Therapeutic Approaches Hwang, Sean T.
2019
4 p. 1-10
article
60 In Vivo Imaging of Neuroinflammatory Targets in Treatment-Resistant Epilepsy Sharma, Ayushe A.

4 article
61 Is it time for drug sensitivity genetic screening? Bazil, Carl W.
2009
4 p. 268-269
article
62 Limb–Girdle and Congenital Muscular Dystrophies: Current Diagnostics, Management, and Emerging Technologies Tesi Rocha, Carolina
2010
4 p. 267-276
article
63 Mammalian Target of Rapamycin (mTOR) Inhibition: Potential for Antiseizure, Antiepileptogenic, and Epileptostatic Therapy Ryther, Robin C. C.
2012
4 p. 410-418
article
64 Management of Elderly Patients with Glioblastoma Roth, Patrick
2017
4 p. 1-7
article
65 Management of Functional Vision Disorders Phansalkar, Ragini

4 p. 265-273
article
66 Management Strategies for Comorbid Supine Hypertension in Patients with Neurogenic Orthostatic Hypotension Isaacson, Stuart H.

4 article
67 Managing Migraine During Pregnancy and Lactation Wells, Rebecca Erwin
2016
4 p. 1-24
article
68 Many options for epilepsy: Comparisons of first- and second-generation AEDs Bazil, Carl W.
2008
4 p. 323-324
article
69 Memory and the brain: Beyond intracranial phrenology Drachman, David A.
2008
4 p. 269-273
article
70 Meningioma Fathi, Ali-Reza
2013
4 p. 1-8
article
71 Microenvironmental Clues for Glioma Immunotherapy Platten, Michael
2014
4 p. 1-10
article
72 Middle Meningeal Artery Embolization in the Management of Chronic Subdural Hematoma: a Comprehensive Review of Current Literature Desir, Likowsky L.

4 p. 109-119
article
73 Migraine in Pregnancy and Lactation David, Paru S.
2014
4 p. 1-6
article
74 Mild Cognitive Impairment in Parkinson’s Disease Aarsland, Dag
2011
4 p. 371-378
article
75 Mild Cognitive Impairment in Parkinson’s Disease—What Is It? Weil, Rimona S.
2018
4 p. 1-11
article
76 Modern Sedation and Analgesia Strategies in Neurocritical Care Bauerschmidt, Andrew

4 p. 149-158
article
77 Molecular Biology of Pediatric Brain Tumors and Impact on Novel Therapies Hoffman, Lindsey M.
2015
4 p. 1-10
article
78 Neurocritical Care Recovery Clinics: An Idea Whose Time Has Come Salasky, Vanessa

4 p. 159-166
article
79 Neurogenic Changes in the Upper Airway of Obstructive Sleep Apnoea Saboisky, Julian P.
2015
4 p. 1-7
article
80 Neurohospitalists: An Emerging Subspecialty Chang, Ira
2012
4 p. 481-488
article
81 Neuroimaging and transcranial ultrasonography in Parkinson’s disease Mehta, Shyamal H.
2008
4 p. 297-303
article
82 Neuroimaging in Epilepsy Middlebrooks, Erik H.
2017
4 p. 1-11
article
83 Neuroinflammation and Non-motor Symptoms: The Dark Passenger of Parkinson’s Disease? Barnum, Christopher J.
2012
4 p. 350-358
article
84 Neurological Complications of Cardiac Tumors Rosário, Madalena
2019
4 p. 1-7
article
85 Neurological Counterparts of Hyponatremia: Pathological Mechanisms and Clinical Manifestations Podestà, Manuel Alfredo
2015
4 p. 1-10
article
86 Neurologic Complications of Commonly Used Drugs in the Hospital Setting Dawson, Elliot T.
2016
4 p. 1-16
article
87 Neurologic Complications of Sickle Cell Disease Farooq, Shama
2019
4 p. 1-8
article
88 Neuroprotection in Parkinson’s disease: Myth or reality? Voss, Tiffini
2008
4 p. 304-309
article
89 Neuroprotection Trials in Traumatic Brain Injury Chakraborty, Shamik
2016
4 p. 1-8
article
90 New insights into the organization of the basal ganglia Koprich, James B.
2009
4 p. 298-304
article
91 New molecular targets for antiepileptic drugs: α2δ, SV2A, and Kv7/KCNQ/M potassium channels Rogawski, Michael A.
2008
4 p. 345-352
article
92 New Options (or not) for Treatment of Idiopathic Intracranial Hypertension Falardeau, Julie

4 p. 257-264
article
93 Nontraumatic Subarachnoid Hemorrhage of the Convexity Bruno, Verónica Andrea
2013
4 p. 1-3
article
94 Novel Approaches to Optimization of Levodopa Therapy for Parkinson’s Disease Kianirad, Yasaman
2016
4 p. 1-6
article
95 Of Monkeys and Men: Analysis of the Phase 2 Double-Blind, Sham-Surgery Controlled, Randomized Trial of AAV2-Neurturin Gene Therapy for Parkinson’s Disease Huddleston, Daniel E.
2011
4 p. 345-348
article
96 Paraneoplastic movement disorders Mehta, Shyamal H.
2009
4 p. 285-291
article
97 Parkinson’s Disease Dementia Docherty, Mary J.
2010
4 p. 292-298
article
98 Parkinson’s Disease, Parkinsonisms, and Mitochondria: the Role of Nuclear and Mitochondrial DNA Legati, A.

4 p. 131-147
article
99 Phenotypic Differences in Dyt1 Between Ethnic Groups Lee, Woong-Woo
2012
4 p. 341-347
article
100 Phenotypic Spectrum of Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS) Pearson, Toni S.
2013
4 p. 1-9
article
101 Post-Traumatic Sleep-Wake Disorders Mollayeva, Tatyana
2017
4 p. 1-23
article
102 Practice Update: Review of Anticonvulsant Therapy Chong, Derek J.
2016
4 p. 1-14
article
103 Pregnancy registries: What do they mean to clinical practice? Gerard, Elizabeth
2008
4 p. 325-332
article
104 Primary Brain Tumors in the Elderly Nayak, Lakshmi
2010
4 p. 252-258
article
105 Prognosis of Intractable Epilepsy: Is Long-Term Seizure Freedom Possible with Medical Management? Munger Clary, Heidi
2011
4 p. 409-417
article
106 Prognostic Value of EEG in Patients after Cardiac Arrest—An Updated Review Muhlhofer, Wolfgang
2018
4 p. 1-15
article
107 Prolonged Postictal Suppression: A Potential Marker for Higher Risk of SUDEP, a Clue to Mechanism, or Both? Bazil, Carl W.
2011
4 p. 349-350
article
108 Recent Advances in Clinical Trials in Multiple System Atrophy Bendetowicz, David

4 p. 95-112
article
109 Recent Advances in the Genetics of Mitochondrial Encephalopathies Tucker, Elena J.
2010
4 p. 277-285
article
110 Recent Developments in Our Understanding of the Semiology and Treatment of Psychogenic Nonepileptic Seizures Goldstein, Laura H.
2012
4 p. 436-444
article
111 Redefining Parkinson’s Disease Research Using Induced Pluripotent Stem Cells Pu, Jiali
2012
4 p. 392-398
article
112 Rescue Therapies for Seizures Poukas, Valeriya S.
2011
4 p. 418-422
article
113 Seizures, illicit drugs, and ethanol Brust, John C. M.
2008
4 p. 333-338
article
114 Selecting Patients for Epilepsy Surgery Unnwongse, Kanjana
2010
4 p. 299-307
article
115 Sleep Dysfunction and Grey Matter Volume Paulekiene, Gintare

4 p. 275-283
article
116 Sleep-Related Changes Prior to Cognitive Dysfunction Pérez-Carbonell, Laura

4 p. 177-183
article
117 Sodium and Fluid Management in Acute Brain Injury Wright, Wendy L.
2012
4 p. 466-473
article
118 Special populations: The management of seizures in HIV-positive patients Mullin, Paul

4 p. 308-314
article
119 Subtypes of Parkinson’s Disease: What Do They Tell Us About Disease Progression? Fereshtehnejad, Seyed-Mohammad
2017
4 p. 1-10
article
120 Sudden Unexpected Death in Epilepsy Nei, Maromi
2010
4 p. 319-326
article
121 Suicidality in Epilepsy and Possible Effects of Antiepileptic Drugs Mula, Marco
2010
4 p. 327-332
article
122 α-Synuclein and Parkinsonism: Updates and Future Perspectives Rosborough, Kaie
2017
4 p. 1-11
article
123 Targeted Therapy in Pediatric Low-Grade Glioma Kilday, John-Paul
2014
4 p. 1-9
article
124 Targeted Treatment of Brain Metastases Shonka, Nicole
2017
4 p. 1-12
article
125 Telehealth in Multiple Sclerosis Clinical Care and Research Xiang, Xinran Maria

4 article
126 The clinical approach to the identification of higher-order visual dysfunction in neurodegenerative disease Pelak, Victoria S.

4 p. 229-242
article
127 The Impact of Aging on Multiple Sclerosis Goyne, Christopher E.

4 p. 83-93
article
128 Therapy in Huntington’s Disease: Where Are We? Nance, Martha A.
2012
4 p. 359-366
article
129 The Relationship Between Herpes Zoster and Stroke Nagel, Maria A.
2015
4 p. 1-4
article
130 The Relationship Between Herpes Zoster and Stroke Nagel, Maria A.

4 article
131 The Role of Brain Tumor Advocacy Groups Rhee, Michele
2014
4 p. 1-7
article
132 The Role of Genetic Testing for Parkinson’s Disease Cook, Lola

4 article
133 The Role of Neuroinflammation in Dementias Pasqualetti, Giuseppe
2015
4 p. 1-11
article
134 The Role of Vascular Imaging in the Initial Assessment of Patients with Acute Ischemic Stroke Qazi, Emmad
2016
4 p. 1-9
article
135 The Use of Oral Disease-Modifying Therapies in Multiple Sclerosis Kretzschmar, Benedikt
2016
4 p. 1-13
article
136 Thunderclap Headache Dilli, Esma
2014
4 p. 1-12
article
137 Transition of Children with Neurological Disorders Tilton, Ann H.
2018
4 p. 1-7
article
138 Treatment of Pediatric Low-Grade Gliomas Sait, Sameer Farouk

4 p. 185-199
article
139 Update on Anticonvulsant Drugs Chong, Derek J.
2010
4 p. 308-318
article
140 Update on Multimodality Monitoring Miller, Chad M.
2012
4 p. 474-480
article
141 Update on the Genetics of Spastic Paraplegias Boutry, Maxime
2019
4 p. 1-19
article
142 Urate in Parkinson’s Disease: More Than a Biomarker? Chen, Xiqun
2012
4 p. 367-375
article
143 Vaccines in Multiple Sclerosis Williamson, Eric M. L.
2016
4 p. 1-8
article
144 Value of genetic models in understanding the cause and mechanisms of Parkinson’s disease Moore, Darren J.
2008
4 p. 288-296
article
145 Vertigo as a Migraine Phenomenon Cherian, Neil
2013
4 p. 1-6
article
146 Web alert 2008
4 p. 274-275
article
147 What Is Intractable Epilepsy, and When (If Ever) Does It Remit with Medical Treatment? Bazil, Carl W.
2010
4 p. 249-251
article
148 What Is the Role of Genetic Testing in Movement Disorders Practice? Schneider, Susanne A.
2011
4 p. 351-361
article
149 What’s new in dystonia? Shanker, Vicki
2009
4 p. 278-284
article
150 When the Ends Are Really the Beginnings: Targeting Telomerase for Treatment of GBM Bollam, Saumya R.
2018
4 p. 1-9
article
151 Who is at Risk of Parkinson Disease? Refining the Preclinical Phase of GBA1 and LRRK2 Variant Carriers: a Clinical, Biochemical, and Imaging Approach Menozzi, Elisa

4 p. 121-130
article
                             151 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands